Antisocial behavioral syndromes and return to drug use following residential relapse prevention/health education treatment.
This study compared residential addiction treatment clients meeting full DSM-III-R criteria for antisocial personality disorder (ASPD) with those reporting syndromal levels of antisocial behavior only in adulthood (AABS) on time to and severity of first posttreatment drug use. Antisocial syndrome and selected other mental disorders were assessed using the Diagnostic Interview Schedule, Revised for DSM-III-R, and validity of self-reported posttreatment drug behavior was measured against results of hair analysis. Among subjects followed within 180 days after treatment exit, individuals with ASPD were at modestly increased risk of a first lapse episode compared to those with AABS. However, the two groups did not differ in severity of lapse. Participants with ASPD demonstrated poorer agreement between self-reported posttreatment drug behavior and hair data. These results add to the evidence suggesting that the DSM requirement for childhood onset in ASPD may be clinically important among substance abusers in identifying a severely antisocial and chronically addicted group at elevated risk for early posttreatment recidivism. Our findings support the importance of careful classification of antisocial syndromes among substance abusers and the identification of characteristics of these syndromes that underlie clients' risks for posttreatment return to drug use to provide optimally individualized treatment planning.
Goldstein
R B
RB
Center for Community Health, Department of Psychiatry, University of California at Los Angeles 90024-6513, USA.
Bigelow
C
C
McCusker
J
J
Lewis
B F
BF
Mundt
K A
KA
Powers
S I
SI
D000328:Adult; D000987:Antisocial Personality Disorder / Q000523:psychology*; D001526:Behavioral Symptoms / Q000523:psychology*; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D011569:Psychiatric Status Rating Scales; D012008:Recurrence; D012114:Residential Treatment; D012650:Self Disclosure; D015813:Substance Abuse Detection / Q000523:psychology; D019966:Substance-Related Disorders / Q000503:physiopathology / Q000523:psychology*; D013997:Time Factors